- EU | ICH M14 Becomes Legally Effective — Strengthening Methodological Expectations for RWD-Based Safety Studies Gallery
EU | ICH M14 Becomes Legally Effective — Strengthening Methodological Expectations for RWD-Based Safety Studies
2026, EMA, EU, March 2026, Members-Only, RWD to Support Reg Decisions, Secondary Use of Existing Data, Significant Update
EU | ICH M14 Becomes Legally Effective — Strengthening Methodological Expectations for RWD-Based Safety Studies
Please login to view this page.
EU | EU Pharma Package Moves Toward Formal Adoption — Major Reform of Pharmaceutical Legislation
Please login to view this page.
EU | HTA Coordination Group Publishes 2025 Annual Report on First Year of EU HTA Regulation Implementation
Please login to view this page.
EU | ENCePP Publishes 2025 Annual Activity Report Highlighting New Working Groups and RWE Priorities
Please login to view this page.
EU | EMA Publishes New GVP Module on Pregnancy and Breastfeeding — Implications for Real-World Safety Research
Please login to view this page.
EU | ICH M14 Guideline on Non-Interventional Studies Using RWD Becomes Legally Effective — Implications for EU Pharmacovigilance Practice
Please login to view this page.
EU | Updates to Regulation (EU) No 520/2012 — Key Pharmacovigilance Changes Applicable from 12 February 2026
Please login to view this page.
EU | European Commission Proposes Health Innovation Package to Strengthen Biotech, Medical Devices and Cardiovascular Health
Please login to view this page.
EU | EMA and HMA Highlight Role of Alzheimer’s Disease Patient Registries in Addressing Evidence Gap
Please login to view this page.










